Immune Checkpoint Inhibitors result in a variety of adverse events. What is the newly emerging overlap syndrome that is associated with a high mortality?
Myocarditis, myositis and myasthenia gravis. In a recent letter to the editor, Lipe DM et al. describe several reported cases of myocarditis occcuring concurrently with myositis and myasthenia gravis. The authors suggest that this syndrome should be considered when patients present with nonspecific and bulbar symptoms,
Lipe DM et al. Cardiotoxicity of Immune Checkpoint Inhibitors: Beyond Myocarditis. JMT 2022; 18: 63-64.